Is there a sweet spot for Nrf2 activation in the treatment of diabetic kidney disease?

Diabetes. 2014 Sep;63(9):2904-5. doi: 10.2337/db14-0829.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Animals
  • Atherosclerosis / prevention & control*
  • Diabetes Mellitus, Experimental / metabolism*
  • Diabetic Nephropathies / drug therapy*
  • Male
  • Oleanolic Acid / analogs & derivatives*
  • Oleanolic Acid / therapeutic use

Substances

  • dh404 compound
  • Oleanolic Acid